Our previous cancer and obesity studies identified BDNF as the key brain mediator for improved metabolic and immunity outcomes following EE, and our EE-BTBR study found that Bdnf and Ntrk2 were upregulated following EE. The gene discussed is NTRK2; the disease is obesity due to melanocortin 4 receptor deficiency.